<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Topiramate for neuropathic pain and fibromyalgia in adults - Wiffen, PJ - 2013 | Cochrane Library</title> <meta content="Topiramate for neuropathic pain and fibromyalgia in adults - Wiffen, PJ - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008314.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Topiramate for neuropathic pain and fibromyalgia in adults - Wiffen, PJ - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008314.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD008314.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Topiramate for neuropathic pain and fibromyalgia in adults" name="citation_title"/> <meta content="Philip J Wiffen" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Sheena Derry" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="sheena.derry@ndcn.ox.ac.uk" name="citation_author_email"/> <meta content="Michael PT Lunn" name="citation_author"/> <meta content="National Hospital for Neurology and Neurosurgery" name="citation_author_institution"/> <meta content="R Andrew Moore" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD008314.pub3" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/08/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008314.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008314.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008314.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Diabetic Neuropathies [*drug therapy]; Fibromyalgia [*drug therapy]; Fructose [adverse effects, *analogs &amp; derivatives, therapeutic use]; Neuralgia [*drug therapy]; Neuroprotective Agents [adverse effects, *therapeutic use]; Randomized Controlled Trials as Topic; Topiramate" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008314.pub3&amp;doi=10.1002/14651858.CD008314.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="7LavyS58";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008314\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008314\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008314.pub3",title:"Topiramate for neuropathic pain and fibromyalgia in adults",firstPublishedDate:"Aug 30, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neuromuscular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7LavyS58&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008314.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008314.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD008314.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD008314.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008314.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD008314.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008314.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD008314.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD008314.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008314.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5416 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008314.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/full#CD008314-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/full#CD008314-sec-0080"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/full#CD008314-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/full#CD008314-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/full#CD008314-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/full#CD008314-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/full#CD008314-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/full#CD008314-sec-0074"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/appendices#CD008314-sec-0085"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/table_n/CD008314StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/table_n/CD008314StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Topiramate for neuropathic pain and fibromyalgia in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/information#CD008314-cr-0002">Philip J Wiffen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/information#CD008314-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Sheena Derry</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/information#CD008314-cr-0004">Michael PT Lunn</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008314.pub3/information#CD008314-cr-0005">R Andrew Moore</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/information/en#CD008314-sec-0095">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 August 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008314.pub3">https://doi.org/10.1002/14651858.CD008314.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008314-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008314-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008314-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008314-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008314-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008314-abs-0001" lang="en"> <section id="CD008314-sec-0001"> <h3 class="title" id="CD008314-sec-0001">Background</h3> <p>Topiramate is an antiepileptic drug with multiple possible mechanisms of action. Antiepileptic drugs are widely used to treat chronic neuropathic pain (pain due to nerve damage) and fibromyalgia, and many guidelines recommend them. </p> </section> <section id="CD008314-sec-0002"> <h3 class="title" id="CD008314-sec-0002">Objectives</h3> <p>To assess the analgesic efficacy and associated adverse events of topiramate for chronic neuropathic pain and fibromyalgia in adults (aged 18 years and above). </p> </section> <section id="CD008314-sec-0003"> <h3 class="title" id="CD008314-sec-0003">Search methods</h3> <p>On 8 May 2013, we searched the Cochrane Neuromuscular Disease Group Specialized Register, CENTRAL, MEDLINE, and EMBASE. We reviewed the bibliographies of all randomised trials identified and review articles, and also searched two clinical trial databases, ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform, to identify additional published or unpublished data. </p> </section> <section id="CD008314-sec-0004"> <h3 class="title" id="CD008314-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) with double‐blind assessment of participant outcomes following two weeks of treatment or longer (though the emphasis of the review was on studies of eight weeks or longer) that used a placebo or active comparator. </p> </section> <section id="CD008314-sec-0005"> <h3 class="title" id="CD008314-sec-0005">Data collection and analysis</h3> <p>We extracted efficacy and adverse event data, and two study authors examined issues of study quality independently. We performed analysis using two tiers of evidence. The first tier used data where studies reported the outcome of at least 50% pain reduction from baseline, lasted at least eight weeks, had a parallel group design, included 200 or more participants in the comparison, and reported an intention‐to‐treat analysis. First tier studies did not use last‐observation‐carried‐forward (LOCF) or other imputation methods for dropouts. The second tier used data that failed to meet this standard; second tier results were therefore subject to potential bias. </p> </section> <section id="CD008314-sec-0006"> <h3 class="title" id="CD008314-sec-0006">Main results</h3> <p>We included four studies with 1684 participants. Three parallel‐group placebo comparisons were in painful diabetic neuropathy (1643 participants), and one cross‐over study with diphenhydramine as an active placebo (41 participants) was in lumbar radiculopathy. Doses of topiramate were titrated up to 200 mg/day or 400 mg/day. All studies had one or more sources of potential major bias, as they either used LOCF imputation or were of small size. </p> <p>No study provided first tier evidence for an efficacy outcome. There was no convincing evidence for efficacy of topiramate at 200 to 400 mg/day over placebo. </p> <p>Eighty‐two per cent of participants taking topiramate 200 to 400 mg/day experienced at least one adverse event, as did 71% with placebo, and the number needed to treat for an additional harmful effect (NNTH) was 8.6 (95% confidence interval (CI) 4.9 to 35). There was no difference in serious adverse events recorded (6.6% versus 7.5%). Adverse event withdrawals with 400 mg daily were much more common with topiramate (27%) than with placebo (8%), with an NNTH of 5.4 (95% CI 4.3 to 7.1). Lack of efficacy withdrawal was less frequent with topiramate (12%) than placebo (18%). Weight loss was a common event in most studies. No deaths attributable to treatment were reported. </p> </section> <section id="CD008314-sec-0007"> <h3 class="title" id="CD008314-sec-0007">Authors' conclusions</h3> <p>Topiramate is without evidence of efficacy in diabetic neuropathic pain, the only neuropathic condition in which it has been adequately tested. The data we have includes the likelihood of major bias due to LOCF imputation, where adverse event withdrawals are much higher with active treatment than placebo control. Despite the strong potential for bias, no difference in efficacy between topiramate and placebo was apparent. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008314-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008314-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008314-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008314-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008314-abs-0004">Français</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008314-abs-0003" lang="en"> <h3>Topiramate for treating neuropathic pain or fibromyalgia</h3> <p>Neuropathic pain is pain coming from damaged nerves. It is different from pain messages carried along healthy nerves from damaged tissue (for example from a fall, a cut, or arthritic knee). Neuropathic pain is treated by different medicines than pain from damaged tissue. Medicines like paracetamol or ibuprofen are not effective in treating neuropathic pain, while medicines that are sometimes used to treat depression or epilepsy can be very effective in some people with neuropathic pain. Our knowledge about fibromyalgia is even less advanced, but fibromyalgia can respond to the same medicines as neuropathic pain. </p> <p>Topiramate is a medicine used to treat epilepsy, and so it might be a useful medicine for neuropathic pain or fibromyalgia. </p> <p>On 8 May 2013, we performed searches to look for clinical trials on the use of topiramate to treat neuropathic pain or fibromyalgia. We found four studies of reasonable quality that tested topiramate against placebo for a number of weeks. Almost all of the 1684 people in the studies had painful limbs because of damaged nerves caused by diabetes. </p> <p>Topiramate did not help the pain and was no different from placebo except in causing more side‐effects, which made many more people withdraw from the studies early. About 3 people in 10 withdrew because of side‐effects with topiramate compared with 1 in 10 with placebo. </p> <p>Topiramate has not been shown to work as a pain medicine in diabetic neuropathy.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008314-sec-0080" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008314-sec-0080"></div> <h3 class="title" id="CD008314-sec-0081">Implications for practice</h3> <section id="CD008314-sec-0081"> <p>There is no evidence that topiramate is effective in treating diabetic neuropathic pain or fibromyalgia. Use of topiramate should be restricted to experienced pain physicians in particular clinical situations. </p> </section> <h3 class="title" id="CD008314-sec-0082">Implications for research</h3> <section id="CD008314-sec-0082"> <p>There is sufficient evidence that topiramate is ineffective to make further research in this area unnecessary, with the possible exception of retrospective individual patient data analysis from studies already completed, in order to generate hypotheses and insights. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD008314-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD008314-sec-0022"></div> <div class="table" id="CD008314-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Topiramate 200 to 400 mg versus placebo for neuropathic pain</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Intervention: topiramate 200 to 400 mg compared with placebo</b> </p> <p><b>Patient or population: neuropathic pain (two studies found in painful diabetic neuropathy, and one in lumbar radiculopathy)</b> </p> <p><b>Settings: community</b> </p> <p><b>Intervention: oral topiramate 200 to 400 mg daily</b> </p> <p><b>Comparison: oral placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcome</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Probable outcome with intervention</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Probable outcome with comparator</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>NNTB or NNTH and/or relative effect (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Number of participants</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At least 50% reduction in pain or equivalent</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diabetic peripheral neuropathy</p> <p>LOCF imputation makes any estimate an overestimation, and bulk of data in studies report no difference between topiramate and placebo<br/> Low numbers </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"Moderate" benefit</p> <p>At least 30% reduction in pain</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diabetic peripheral neuropathy</p> <p>LOCF imputation makes any estimate an overestimation, and bulk of data in studies report no difference between topiramate and placebo<br/> Low numbers </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion below 30/100 mm on VAS</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient Global Impression of Change much or very much improved</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>399 participants</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Variously reported, and inadequate numbers for satisfactory analysis</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse event withdrawals</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>270 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>81 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNTH 5.4 (4.3 to 7.1)</p> <p>RR 3.4 (2.4 to 4.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1038 participants</p> <p>178 events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low number of events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>66 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>75 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNTH not calculated</p> <p>RR 0.9 (0.6 to 1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1586 participants</p> <p>110 events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low number of events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>There were no deaths related to treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>LOCF: last observation carried forward; VAS: visual analogue scale; NNTB: number needed to treat for an additional beneficial effect: NNTH: number needed to treat for an additional harmful effect; RR: risk ratio. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008314-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD008314-sec-0023"></div> <section id="CD008314-sec-0024"> <h3 class="title" id="CD008314-sec-0024">Description of the condition</h3> <p>The 2011 International Association for the Study of Pain definition of neuropathic pain is "pain caused by a lesion or disease of the somatosensory system" (<a href="./references#CD008314-bbs2-0031" title="JensenTS , BaronR , HaanpääM , KalsoE , LoeserJD , RiceAS , et al. A new definition of neuropathic pain. Pain2011; Vol. 152, issue 10:2204‐5. [DOI: 10.1016/j.pain.2011.06.017] ">Jensen 2011</a>), based on an earlier consensus meeting (<a href="./references#CD008314-bbs2-0071" title="TreedeRD , JensenTS , CampbellJN , CruccuG , DostrovskyJO , GriffinJW , et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology2008;70(18):1630‐5. [DOI: 10.1212/01.wnl.0000282763.29778.59] ">Treede 2008</a>). Neuropathic pain may be caused by nerve damage, but it is often followed by changes in the central nervous system (CNS) (<a href="./references#CD008314-bbs2-0043" title="MoissetX , BouhassiraD . Brain imaging of neuropathic pain. NeuroImage2007;37 Suppl 1:S80‐8. [DOI: 10.1016/j.neuroimage.2007.03.054] ">Moisset 2007</a>). It is complex (<a href="./references#CD008314-bbs2-0012" title="ApkarianAV , HashmiJA , BalikiMN . Pain and the brain: specificity and plasticity of the brain in clinical chronic pain. Pain2011;152(3 Suppl):S49‐64. [DOI: 10.1016/j.pain.2010.11.010] ">Apkarian 2011</a>; <a href="./references#CD008314-bbs2-0070" title="TraceyI . Can neuroimaging studies identify pain endophenotypes in humans?. Nature Reviews. Neurology2011;7(3):173‐81. [DOI: 10.1038/nrneurol.2011.4] ">Tracey 2011</a>), and neuropathic pain features can be found in patients with joint pain (<a href="./references#CD008314-bbs2-0064" title="SoniA , BatraR , GwilymS , SpectorT , HartD , ArdenN , et al. Neuropathic features of joint pain: a community‐based study. Arthritis &amp; Rheumatism2013;65(7):1942‐9. [DOI: 10.1002/art.37962] ">Soni 2013</a>). Moreover, patients with neuropathic pain and fibromyalgia experience similar sensory phenomena (<a href="./references#CD008314-bbs2-0037" title="KoroschetzJ , RehmSE , GockelU , BroszM , FreynhagenR , TölleTR , et al. Fibromyalgia and neuropathic pain‐‐differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia. BMC Neurology2011;11:55. [DOI: 10.1186/1471‐2377‐11‐55] ">Koroschetz 2011</a>). </p> <p>Neuropathic pain tends to be chronic and may be present for months or years. Fibromyalgia is defined as widespread pain for longer than three months with pain on palpation at 11 or more of 18 specified tender points (<a href="./references#CD008314-bbs2-0077" title="WolfeF , SmytheHA , YunusMB , BennettRM , BombardierC , GoldenbergDL , et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism1990;33(2):160‐72. [PUBMED: 2306288] ">Wolfe 1990</a>), and it is frequently associated with other symptoms, such as poor sleep, fatigue, and depression. More recently, a definition of fibromyalgia has been proposed based on symptom severity and the presence of widespread pain (<a href="./references#CD008314-bbs2-0078" title="WolfeF , ClauwDJ , FitzcharlesMA , GoldenbergDL , KatzRS , MeaseP , et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care &amp; Research2010;62(5):600‐10. [DOI: 10.1002/acr.20140] ">Wolfe 2010</a>). The cause, or causes, are not well understood, but it has features in common with neuropathic pain, including changes in the CNS. Many people with these conditions are significantly disabled with moderate or severe pain for many years. </p> <p>In primary care in the UK the incidences, per 100,000 person years observation, have been reported as 28 (95% CI 27 to 30) for postherpetic neuralgia, 27 (95% CI 26 to 29) for trigeminal neuralgia, 0.8 (95% CI 0.6 to 1.1) for phantom limb pain, and 21 (95% CI 20 to 22) for painful diabetic neuropathy (<a href="./references#CD008314-bbs2-0028" title="HallGC , CarrollD , McQuayHJ . Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002‐2005. BMC Family Practice2008;9:26. [DOI: 10.1186/1471‐2296‐9‐26] ">Hall 2008</a>). Estimates vary between studies, often because of small numbers of cases. The incidence of trigeminal neuralgia has been estimated at 4 in 100,000 per year (<a href="./references#CD008314-bbs2-0034" title="KatusicS , WilliamsDB , BeardCM , BergstralhEJ , KurlandLT . Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota,1945‐1984. Neuroepidemiology1991;10(5‐6):276‐81. ">Katusic 1991</a>; <a href="./references#CD008314-bbs2-0061" title="RappaportZH , DevorM . Trigeminal neuralgia: the role of self‐sustaining discharge in the trigeminal ganglion. Pain1994;56(2):127‐38. [PUBMED: 8008402 ] ">Rappaport 1994</a>), while more recently, a study of facial pain in The Netherlands found incidences per 100,000 person years of 12.6 for trigeminal neuralgia and 3.9 for postherpetic neuralgia (<a href="./references#CD008314-bbs2-0036" title="KoopmanJS , DielemanJP , HuygenFJ , deMosM , MartinCG , SturkenboomMC . Incidence of facial pain in the general population. Pain2009;147(1‐3):122‐7. [DOI: 10.1016/j.pain.2009.08.023] ">Koopman 2009</a>). A systematic review of chronic pain demonstrated that some neuropathic pain conditions, such as painful diabetic neuropathy, can be more common, with prevalence rates up to 400 per 100,000 person years (<a href="./references#CD008314-bbs2-0042" title="McQuayHJ , SmithLA , MooreRA . Chronic Pain. In: StevensA , RafteryJ , MantJ , SimpsonS editor(s). Health Care Needs Assessment: The Epidemiologically Based Needs Assessment Reviews: Third Series. Oxford: Radcliffe Publishing Ltd, 2007. [ISBN: 978‐1‐84619‐063‐6] ">McQuay 2007</a>) illustrating how common the condition was as well as its chronicity. The prevalence of neuropathic pain was reported as being 3.3% in Austria (<a href="./references#CD008314-bbs2-0026" title="GustorffB , DornerT , LikarR , GrisoldW , LawrenceK , SchwarzF , et al. Prevalence of self‐reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiologica Scandinavica2008;52(1):132‐6. [DOI: 10.1111/j.1399‐6576.2007.01486.x] ">Gustorff 2008</a>), 6.9% in France (<a href="./references#CD008314-bbs2-0015" title="BouhassiraD , Lantéri‐MinetM , AttalN , LaurentB , TouboulC . Prevalence of chronic pain with neuropathic characteristics in the general population. Pain2008;136(3):380‐7. [DOI: 10.1016/j.pain.2007.08.013] ">Bouhassira 2008</a>), as high as 8% in the UK (<a href="./references#CD008314-bbs2-0069" title="TorranceN , SmithBH , BennettMI , LeeAJ . The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. Journal of Pain2006;7(4):281‐9. [DOI: 10.1016/j.jpain.2005.11.008] ">Torrance 2006</a>), and about 7% in a systematic review of studies published since 2000 (<a href="./references#CD008314-bbs2-0057" title="MooreRA , DerryS , TaylorRS , StraubeS , PhillipsCJ . The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice2014;14(1):79‐94. [DOI: 10.1111/papr.12050] ">Moore 2014</a>). Some forms of neuropathic pain, such as diabetic neuropathy and postsurgical chronic pain (which is often neuropathic in origin) are increasing (<a href="./references#CD008314-bbs2-0028" title="HallGC , CarrollD , McQuayHJ . Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002‐2005. BMC Family Practice2008;9:26. [DOI: 10.1186/1471‐2296‐9‐26] ">Hall 2008</a>). Fibromyalgia is common, especially in women, with an all‐age prevalence of 12% and a female to male ratio of 6:1 (<a href="./references#CD008314-bbs2-0040" title="McNallyJD , MathesonDA , BakowskyVS . The epidemiology of self‐reported fibromyalgia in Canada. Chronic Diseases in Canada2006;27(1):9‐16. ">McNally 2006</a>). </p> <p>Neuropathic pain and fibromyalgia are known to be difficult to treat effectively, with only a minority of individuals experiencing a clinically relevant benefit from any one intervention. A multidisciplinary approach is now advocated, with pharmacological interventions being combined with physical or cognitive interventions, or both. Conventional analgesics are usually not effective. Some patients may derive some benefit from a topical lidocaine patch or low concentration topical capsaicin, though evidence about benefits is uncertain (<a href="./references#CD008314-bbs2-0020" title="DerryS , MooreRA . Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD010111] ">Derry 2012</a>; <a href="./references#CD008314-bbs2-0035" title="KhaliqW , AlamS , PuriNK . Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD004846.pub2] ">Khaliq 2007</a>). High concentration topical lidocaine may benefit some patients with postherpetic neuralgia (<a href="./references#CD008314-bbs2-0021" title="DerryS , RiceASC , ColeP , TanT , MooreRA . Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD007393.pub3] ">Derry 2013</a>). Treatment is more usually by so‐called unconventional analgesics such as antidepressants like duloxetine and amitriptyline (<a href="./references#CD008314-bbs2-0039" title="LunnMP , HughesRAC , WiffenPJ . Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD007115.pub2] ">Lunn 2009</a>; <a href="./references#CD008314-bbs2-0054" title="MooreRA , StraubeS , EcclestonC , DerryS , AldingtonD , WiffenP , et al. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain2012;153(2):265‐8. [DOI: 10.1016/j.pain.2011.10.004] ">Moore 2012a</a>; <a href="./references#CD008314-bbs2-0067" title="SultanA , GaskellH , DerryS , MooreRA . Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurology2008;8:29. [DOI: 10.1186/1471‐2377‐8‐29] ">Sultan 2008</a>) or antiepileptics like gabapentin or pregabalin (<a href="./references#CD008314-bbs2-0046" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009</a>; <a href="./references#CD008314-bbs2-0051" title="MooreRA , WiffenPJ , DerryS , McQuayHJ . Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub2] ">Moore 2011</a>). An overview of treatment guidelines points out some general similarities, but also differences in approach (<a href="./references#CD008314-bbs2-0059" title="O'Connor , AB , DworkinRH . Treatment of neuropathic pain: an overview of recent guidelines. American Journal of Medicine2009;122(10 Suppl):S22‐32. [DOI: 10.1016/j.amjmed.2009.04.007] ">O'Connor 2009</a>). The proportion of patients who achieve worthwhile pain relief (typically at least 50% pain intensity reduction (<a href="./references#CD008314-bbs2-0056" title="MooreRA , StraubeS , AldingtonD . Pain measures and cut‐offs ‐ 'no worse than mild pain' as a simple, universal outcome. Anaesthesia2013;68(4):400‐12. [DOI: 10.1111/anae.12148] ">Moore 2013</a>)) is small, generally 10% to 25% more than with placebo, with the number needed to treat for an additional beneficial outcome (NNTB) usually between 4 and 10. </p> <p>Chronic painful conditions comprised five of the 11 top‐ranking conditions for years lived with disability in 2010 (<a href="./references#CD008314-bbs2-0072" title="VosT , FlaxmanAD , NaghaviM , LozanoR , MichaudC , EzzatiM , et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2012;380(9859):2163‐96. [DOI: 10.1016/S0140‐6736(12)61729‐2] ">Vos 2012</a>), and are responsible for considerable loss of quality of life and employment, and increased health costs (<a href="./references#CD008314-bbs2-0057" title="MooreRA , DerryS , TaylorRS , StraubeS , PhillipsCJ . The costs and consequences of adequately managed chronic non‐cancer pain and chronic neuropathic pain. Pain Practice2014;14(1):79‐94. [DOI: 10.1111/papr.12050] ">Moore 2014</a>). </p> </section> <section id="CD008314-sec-0025"> <h3 class="title" id="CD008314-sec-0025">Description of the intervention</h3> <p>Topiramate is a weak inhibitor of carbonic anhydrase isoenzymes (<a href="./references#CD008314-bbs2-0033" title="KandaT , KurokawaM , TamuraS , NakamuraJ , IshiiA , KuwanaY , et al. Topiramate reduces abnormally high extracellular levels of glutamate and aspartate in the hippocampus of spontaneously epileptic rats (SER). Life Sciences1996;59(19):1607‐16. [PUBMED: 8913326] ">Kanda 1996</a>). Therefore, it is associated with carbonic anhydrase‐related adverse effects such as nephrolithiasis, metabolic acidosis and potentially a compensatory hyperventilating respiratory alkalosis, and perioral or digital paraesthesias. Other well‐recognised adverse effects of topiramate include somnolence (sleepiness), dizziness, fatigue, nausea, poor concentration, and weight loss (<a href="./references#CD008314-bbs2-0017" title="ChongMS , LibrettoSE . The rationale and use of topiramate for treating neuropathic pain. The Clinical Journal of Pain2003;19(1):59‐68. ">Chong 2003</a>; <a href="./references#CD008314-bbs2-0073" title="WaliaKS , KhanEA , KoDH , RazaSS , KhanYN . Side effects of antiepileptics ‐ a review. Pain Practice2004;4(3):194‐203. [PUBMED: 17173601] ">Walia 2004</a>). Topiramate is associated with weight loss (<a href="./references#CD008314-bbs2-0011" title="AntelJ , HebebrandJ . Weight‐reducing side effects of the antiepileptic agents topiramate and zonisamide. Handbook of Experimental Pharmacology2012;209:433‐66. [DOI: 10.1007/978‐3‐642‐24716‐3_20] ">Antel 2012</a>), and there are reports of reversible anorgasmia in men and women (<a href="./references#CD008314-bbs2-0068" title="SunC , LayC , BronerS , SilbersteinS , TepperS , NewmanL . Reversible anorgasmia with topiramate therapy for headache: a report of 7 patients. Headache2006;46(9):1450‐3. [DOI: 10.1111/j.1526‐4610.2006.00587.x] ">Sun 2006</a>). Topiramate does not appear to be associated with oral cleft or major congenital malformations in the newborn when taken by women during pregnancy (<a href="./references#CD008314-bbs2-0025" title="GreenMW , SeegerJD , PetersonC , BhattacharyyaA . Utilization of topiramate during pregnancy and risk of birth defects. Headache2012;52(7):1070‐84. [DOI: 10.1111/j.1526‐4610.2012.02190.x] ">Green 2012</a>). </p> <p>Topiramate is licensed for the treatment of epilepsy and as a prophylaxis for migraine in the UK and USA. These indications have been the subjects of separate Cochrane reviews (<a href="./references#CD008314-bbs2-0018" title="ChronicleEP , MullenersWM . Anticonvulsant drugs for migraine prophylaxis. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD003226.pub2] ">Chronicle 2004</a>; <a href="./references#CD008314-bbs2-0032" title="JetteN , HemmingK , HuttonJL , MarsonAG . Topiramate add‐on for drug‐resistant partial epilepsy. Cochrane Database of Systematic Reviews2008, Issue 3. [DOI: 10.1002/14651858.CD001417.pub2] ">Jette 2008</a>). Topiramate is taken orally and is available as 25 mg, 50 mg, 100 mg, and 200 mg tablets, and 15 mg, 25 mg, and 50 mg sprinkle capsules. It is marketed under the trade name Topamax®, and generic formulations are available. The dose is usually titrated slowly, to minimise adverse effects, until a therapeutic response is achieved, or tolerability reached. </p> </section> <section id="CD008314-sec-0026"> <h3 class="title" id="CD008314-sec-0026">How the intervention might work</h3> <p>Topiramate has multiple modes of action, some of which are thought to be useful in the treatment of neuropathic pain. Topiramate has been shown to block activity‐dependent, voltage‐gated sodium channels, enhance the action of ɣ‐aminobutyric acid (GABA)‐A receptors, inhibit L‐type voltage‐gated calcium channels, pre‐synaptically reduce glutamate release, and post‐synaptically block kainate/α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA) receptors (<a href="./references#CD008314-bbs2-0017" title="ChongMS , LibrettoSE . The rationale and use of topiramate for treating neuropathic pain. The Clinical Journal of Pain2003;19(1):59‐68. ">Chong 2003</a>), all of which have been reported to be involved in the genesis or control of neuropathic pain. </p> </section> <section id="CD008314-sec-0027"> <h3 class="title" id="CD008314-sec-0027">Why it is important to do this review</h3> <p>Topiramate has been used to treat various neuropathic pain conditions, using various study designs, with conflicting results. It is important to review all the evidence to determine its place in the treatment of neuropathic pain and fibromyalgia. </p> <p>The original review of antiepileptic drugs for neuropathic pain has been withdrawn (<a href="./references#CD008314-bbs2-0074" title="WiffenPJ , CollinsS , McQuayHJ , CarrollD , JadadA , MooreRA . Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD001133.pub3] ">Wiffen 2010</a>, originally published in 2005) and split into reviews for individual drugs, including carbamazepine (<a href="./references#CD008314-bbs2-0075" title="WiffenPJ , DerryS , MooreRA , McQuayHJ . Carbamazepine for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD005451.pub2] ">Wiffen 2011a</a>), lamotrigine (<a href="./references#CD008314-bbs2-0076" title="WiffenPJ , DerryS , MooreRA . Lamotrigine for acute and chronic pain. Cochrane Database of Systematic Reviews2011, Issue 2. [DOI: 10.1002/14651858.CD006044.pub3] ">Wiffen 2011b</a>), gabapentin (<a href="./references#CD008314-bbs2-0051" title="MooreRA , WiffenPJ , DerryS , McQuayHJ . Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub2] ">Moore 2011</a>), pregabalin (<a href="./references#CD008314-bbs2-0046" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009</a>), valproic acid (<a href="./references#CD008314-bbs2-0024" title="GillD , DerryS , WiffenPJ , MooreRA . Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD009183.pub2] ">Gill 2011</a>), phenytoin (<a href="./references#CD008314-bbs2-0014" title="BirseF , DerryS , MooreRA . Phenytoin for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2012, Issue 5. [DOI: 10.1002/14651858.CD009485.pub2] ">Birse 2012</a>), and clonazepam (<a href="./references#CD008314-bbs2-0019" title="CorriganR , DerryS , WiffenPJ , MooreRA . Clonazepam for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews2012, Issue 5. [DOI: 10.1002/14651858.CD009486.pub2] ">Corrigan 2012</a>). These separate reviews for individual drugs use more stringent criteria of validity, which include the level of response obtained, the duration of study, and method of imputation of missing data (<a href="./references#CD008314-bbs2-0054" title="MooreRA , StraubeS , EcclestonC , DerryS , AldingtonD , WiffenP , et al. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain2012;153(2):265‐8. [DOI: 10.1016/j.pain.2011.10.004] ">Moore 2012a</a>). <a href="./appendices#CD008314-sec-0086">Appendix 1</a> gives details of recent changes to the thinking about chronic pain and evidence. </p> <p>This Cochrane review therefore assesses evidence in ways that make both statistical and clinical sense, and uses developing criteria for what constitutes reliable evidence in chronic pain (<a href="./references#CD008314-bbs2-0047" title='MooreRA , EcclestonC , DerryS , WiffenP , BellRF , StraubeS , et al. "Evidence" in chronic pain ‐ establishing best practice in the reporting of systematic reviews. Pain2010;150(3):386‐9. [PUBMED: 20627575] '>Moore 2010a</a>). Studies included and analysed have to meet minimum criteria for reporting quality (blinding, randomisation), validity (duration, dose and timing, diagnosis, outcomes, etc), and size (ideally at least 200 participants in each treatment arm in a comparison in which the number needed to treat for an additional beneficial outcome (NNTB) is four or above (<a href="./references#CD008314-bbs2-0044" title="MooreRA , GavaghanD , TramèrMR , CollinsSL , McQuayHJ . Size is everything ‐ large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain1998;78(3):209‐16. [PUBMED: 9870574] ">Moore 1998</a>)). This does set high standards and marks a departure from how reviews have been done previously. </p> <p>This review will be one of a series to be included in an overview of antiepileptic drugs for neuropathic pain and fibromyalgia. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008314-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008314-sec-0028"></div> <p> <ol id="CD008314-list-0001"> <li> <p>To assess the analgesic efficacy of topiramate for chronic neuropathic pain and fibromyalgia in adults (aged 18 years and above). </p> </li> <li> <p>To assess the adverse events associated with the clinical use of topiramate for chronic neuropathic pain and fibromyalgia in adults. </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008314-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008314-sec-0029"></div> <section id="CD008314-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008314-sec-0031"> <h4 class="title">Types of studies</h4> <p>We included studies if they were randomised controlled trials (RCTs) with double‐blind assessment of participant outcomes following two weeks of treatment or longer, though the emphasis of the review was on studies of eight weeks or longer. We required full journal publication, with the exception of online clinical trial results summaries of otherwise unpublished clinical trials and abstracts with sufficient data for analysis. We did not include short abstracts (usually meeting reports). We excluded studies that were non‐randomised, studies of experimental pain, case reports, and clinical observations. </p> </section> <section id="CD008314-sec-0032"> <h4 class="title">Types of participants</h4> <p>Studies included adult participants aged 18 years and above. Participants could have one or more of a wide range of chronic neuropathic pain conditions, including: </p> <p> <ul id="CD008314-list-0002"> <li> <p>painful diabetic neuropathy;</p> </li> <li> <p>postherpetic neuralgia;</p> </li> <li> <p>trigeminal neuralgia;</p> </li> <li> <p>phantom limb pain;</p> </li> <li> <p>postoperative or traumatic neuropathic pain;</p> </li> <li> <p>complex regional pain syndrome;</p> </li> <li> <p>cancer‐related neuropathy;</p> </li> <li> <p>human immunodeficiency virus (HIV) neuropathy;</p> </li> <li> <p>spinal cord injury;</p> </li> </ul> </p> <p>or</p> <p> <ul id="CD008314-list-0003"> <li> <p>fibromyalgia;</p> </li> <li> <p>complex regional pain syndrome (CRPS) Type I.</p> </li> </ul> </p> <p>If studies included participants with more than one type of neuropathic pain we planned to analyse results according to the primary condition. </p> <p>We excluded migraine and headache studies as they are the subject of another Cochrane review (<a href="./references#CD008314-bbs2-0018" title="ChronicleEP , MullenersWM . Anticonvulsant drugs for migraine prophylaxis. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD003226.pub2] ">Chronicle 2004</a>). </p> </section> <section id="CD008314-sec-0033"> <h4 class="title">Types of interventions</h4> <p>Oral topiramate, at any dose, administered for the relief of neuropathic pain or fibromyalgia and compared to placebo or any active comparator. </p> </section> <section id="CD008314-sec-0034"> <h4 class="title">Types of outcome measures</h4> <p>We anticipated that studies would use a variety of outcome measures, with the majority of studies using standard subjective scales (numerical rating scale (NRS) or visual analogue scale (VAS)) for pain intensity, pain relief, or both. We were particularly interested in Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) definitions for moderate and substantial benefit in chronic pain studies (<a href="./references#CD008314-bbs2-0023" title="DworkinRH , TurkDC , WyrwichKW , BeatonD , CleelandCS , FarrarJT , et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain2008;9(2):105‐21. [DOI: 10.1016/j.jpain.2007.09.005] ">Dworkin 2008</a>). These are defined as at least 30% pain relief over baseline (moderate), at least 50% pain relief over baseline (substantial), much or very much improved on Patient Global Impression of Change (PGIC) (moderate), and very much improved on PGIC (substantial). These outcomes are different from those set out in the earlier review (<a href="./references#CD008314-bbs2-0074" title="WiffenPJ , CollinsS , McQuayHJ , CarrollD , JadadA , MooreRA . Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD001133.pub3] ">Wiffen 2010</a>), concentrating as they do on dichotomous outcomes where pain responses do not follow a normal (Gaussian) distribution. People with chronic pain desire high levels of pain relief, ideally more than 50%, and with pain not worse than mild (<a href="./references#CD008314-bbs2-0058" title="O'BrienEM , StaudRM , HassingerAD , McCullochRC , CraggsJG , AtchisonJW , et al. Patient‐centered perspective on treatment outcomes in chronic pain. Pain Medicine2010;11(1):6‐15. [DOI: 10.1111/j.1526‐4637.2009.00685.x] ">O'Brien 2010</a>). </p> <p>We included a 'Summary of findings' table as set out in the Cochrane Pain, Palliative and Supportive Care Group author guide (<a href="./references#CD008314-bbs2-0060" title="CochranePain , Palliative and Supportive Care Group (PaPaS). PaPaS author and referee guidance. http://papas.cochrane.org/papas‐documents (accessed 22 January 2013). ">PaPaS 2011</a>). The 'Summary of findings' table includes outcomes of at least 30% and at least 50% pain intensity reduction, PGIC, adverse event withdrawals, serious adverse events, and death. </p> <section id="CD008314-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD008314-list-0004"> <li> <p>Patient‐reported pain relief of 30% or greater.</p> </li> <li> <p>Patient‐reported pain relief of 50% or greater.</p> </li> <li> <p>PGIC much or very much improved.</p> </li> <li> <p>PGIC very much improved.</p> </li> </ol> </p> </section> <section id="CD008314-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD008314-list-0005"> <li> <p>Any pain‐related outcome indicating some improvement.</p> </li> <li> <p>Withdrawals due to lack of efficacy.</p> </li> <li> <p>Participants experiencing any adverse event.</p> </li> <li> <p>Participants experiencing any serious adverse event. Serious adverse events typically include any untoward medical occurrence or effect that at any dose results in death, is life‐threatening, requires hospitalisation or prolongation of existing hospitalisation, results in persistent or significant disability or incapacity, is a congenital anomaly or birth defect, is an 'important medical event' that may jeopardise the patient, or may require an intervention to prevent one of the above characteristics or consequences. </p> </li> <li> <p>Withdrawals due to adverse events.</p> </li> <li> <p>Specific adverse events, particularly somnolence and dizziness.</p> </li> <li> <p>Weight loss or weight change.</p> </li> </ol> </p> <p>These outcomes were not eligibility criteria for this review, but were outcomes of interest within included studies. </p> </section> </section> </section> <section id="CD008314-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD008314-sec-0038"> <h4 class="title">Electronic searches</h4> <p>The following databases were searched:</p> <p> <ul id="CD008314-list-0006"> <li> <p>the Cochrane Neuromuscular Disease Group Specialized Register (8 May 12013);</p> </li> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL) in <i>The Cochrane Library</i> (Issue 4, 2013); </p> </li> <li> <p>MEDLINE (January 1966 to April 2013); and</p> </li> <li> <p>EMBASE (January 1980 to April 2013).</p> </li> </ul> </p> <p>The detailed search strategies are in the appendices: <a href="./appendices#CD008314-sec-0087">Appendix 2</a> (MEDLINE), <a href="./appendices#CD008314-sec-0088">Appendix 3</a> (EMBASE), and <a href="./appendices#CD008314-sec-0089">Appendix 4</a> (CENTRAL). </p> </section> <section id="CD008314-sec-0039"> <h4 class="title">Searching other resources</h4> <p>We reviewed the bibliographies of all randomised trials identified and review articles and searched two clinical trial databases (ClinicalTrials.gov (<a href="http://ClinicalTrials.gov" target="_blank">ClinicalTrials.gov</a>) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>)) to identify additional published or unpublished data. We did not contact investigators or study sponsors. </p> </section> </section> <section id="CD008314-sec-0040"> <h3 class="title" id="CD008314-sec-0040">Data collection and analysis</h3> <p>The intention was to perform separate analyses according to particular neuropathic pain conditions or fibromyalgia. Analyses combining different neuropathic pain conditions would be done for exploratory purposes only. </p> <section id="CD008314-sec-0041"> <h4 class="title">Selection of studies</h4> <p>We determined eligibility by reading the abstract of each study identified by the search. We eliminated studies that clearly did not satisfy inclusion criteria, and we obtained full copies of the remaining studies; two review authors made decisions. Two review authors read these studies independently and reached agreement by discussion. We did not anonymise the studies in any way before assessment. We created a PRISMA (Preferred Reporting Items for Systematic Reviews) flow chart to illustrate the study selection process (<a href="#CD008314-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD008314-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA (Preferred Reporting Items for Systematic Reviews) flow chart." data-id="CD008314-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA (Preferred Reporting Items for Systematic Reviews) flow chart.</p> </div> </div> </div> </section> <section id="CD008314-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted data using a standard form and checked for agreement before entry into Review Manager (RevMan) (<a href="./references#CD008314-bbs2-0062" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>) or any other analysis tool. We included information about the pain condition and number of participants treated, drug and dosing regimen, study design (placebo or active control), study duration and follow‐up, analgesic outcome measures and results, withdrawals, and adverse events (participants experiencing any adverse event or serious adverse event). </p> </section> <section id="CD008314-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used the Oxford Quality Score (<a href="./references#CD008314-bbs2-0030" title="JadadAR , MooreRA , CarrollD , JenkinsonC , ReynoldsDJ , GavaghanDJ , et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials1996;17(1):1‐12. [PUBMED: 8721797] ">Jadad 1996</a>) as the basis for inclusion, limiting inclusion to studies that were, as a minimum, randomised and double‐blind. </p> <p>Two authors independently assessed risk of bias for each study, using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD008314-bbs2-0029" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) and adapted from those used by the Cochrane Pregnancy and Childbirth Group, with any disagreements resolved by discussion. We assessed the following for each study. </p> <p> <ol id="CD008314-list-0007"> <li> <p>Random sequence generation (checking for possible selection bias). We assessed the method used to generate the allocation sequence as: low risk of bias (any truly random process, for example random number table; computer random number generator); unclear risk of bias (method used to generate sequence not clearly stated). We excluded studies using a non‐random process (for example, odd or even date of birth; hospital or clinic record number). </p> </li> <li> <p>Allocation concealment (checking for possible selection bias). The method used to conceal allocation to interventions prior to assignment determines whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. We assessed the methods as: low risk of bias (for example, telephone or central randomisation; consecutively numbered sealed opaque envelopes); unclear risk of bias (method not clearly stated). We excluded studies that did not conceal allocation (for example, open list). </p> </li> <li> <p>Blinding of outcome assessment (checking for possible detection bias). We assessed the methods used to blind study participants and outcome assessors from knowledge of which intervention a participant received as: low risk of bias (study states that it was blinded and describes the method used to achieve blinding, for example, identical tablets; matched in appearance and smell); unclear risk of bias (study states that it was blinded but does not provide an adequate description of how it was achieved). We excluded studies that were not double‐blind. </p> </li> <li> <p>Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data). We assessed the methods used to deal with incomplete data as: low risk (&lt; 10% of participants did not complete the study and/or used ‘baseline observation carried forward’ analysis); unclear risk of bias (used 'last observation carried forward' (LOCF) analysis); high risk of bias (used 'completer' analysis). </p> </li> <li> <p>Size of study (checking for possible biases confounded by small size). We assessed studies as being at low risk of bias (≥ 200 participants per treatment arm); unclear risk of bias (50 to 199 participants per treatment arm);high risk of bias (&lt; 50 participants per treatment arm). </p> </li> </ol> </p> </section> <section id="CD008314-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>We calculated the number needed to treat for an additional beneficial outcome (NNTB) as the reciprocal of the absolute risk reduction (ARR) (<a href="./references#CD008314-bbs2-0041" title="McQuayH , MooreR . An Evidence‐Based Resource for Pain Relief. Oxford: Oxford University Press, 1998. [ISBN: 0‐19‐263048‐2] ">McQuay 1998</a>). For unwanted effects, the NNTB becomes the number needed to treat for an additional harmful outcome (NNTH) and is calculated in the same manner. We used dichotomous data to calculate risk ratios (RR) with 95% confidence intervals (CI) using a fixed‐effect model unless significant statistical heterogeneity was found (see below). We did not use continuous data in analyses. </p> </section> <section id="CD008314-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>The control treatment arm would be split between active treatment arms in a single study if the active treatment arms were not combined for analysis. </p> </section> <section id="CD008314-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>We used intention‐to‐treat (ITT) analysis where the ITT population consisted of participants who were randomised, took at least one dose of the assigned study medication, and provided at least one post‐baseline assessment. Missing participants were assigned zero improvement. </p> </section> <section id="CD008314-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>We dealt with clinical heterogeneity by combining studies that examined similar conditions. We assessed statistical heterogeneity visually (<a href="./references#CD008314-bbs2-0038" title="L'AbbéKA , DetskyAS , O'RourkeK . Meta‐analysis in clinical research. Annals of Internal Medicine1987;107(2):224‐33. ">L'Abbé 1987</a>) and with the use of the I² statistic. When I² was greater than 50%, we planned to consider possible reasons. </p> </section> <section id="CD008314-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>The aim of this review was to use dichotomous data of known utility (<a href="./references#CD008314-bbs2-0048" title="MooreRA , StraubeS , PaineJ , PhillipsCJ , DerryS , McQuayHJ . Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain2010;149(2):360‐4. [DOI: 10.1016/j.pain.2010.02.039] ">Moore 2010b</a>). The review did not depend on what authors of the original studies chose to report or not, though clearly difficulties arose in studies failing to report any dichotomous results. If useful, we extracted and used continuous data, which probably poorly reflect efficacy and utility, but did so for illustrative purposes only. </p> <p>We assessed publication bias using a method designed to detect the amount of unpublished data with a null effect required to make any result clinically irrelevant (in this case an NNTB of 10 or higher) (<a href="./references#CD008314-bbs2-0045" title="MooreRA , BardenJ , DerryS , McQuayHJ . Managing potential publication bias. In: McQuayHJ , KalsoE , MooreRA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15‐24. [ISBN: 978–0–931092–69–5] ">Moore 2008</a>). </p> </section> <section id="CD008314-sec-0049"> <h4 class="title">Data synthesis</h4> <p>We used a fixed‐effect model for meta‐analysis.</p> <p>We analysed efficacy data for each painful condition in two tiers, according to outcome and freedom from known sources of bias. </p> <p> <ul id="CD008314-list-0008"> <li> <p>The first tier used data that met current best standards, where studies report the outcome of at least 50% pain intensity reduction over baseline (or its equivalent) without the use of LOCF or other imputation method for dropouts; report an ITT analysis; last eight to 12 weeks or longer; have a parallel group design; and have at least 200 participants (preferably at least 400) in the comparison. We reported these top tier results first. </p> </li> <li> <p>The second tier used any available data, but where one or more of the above conditions were not met, for example, reporting at least 30% pain intensity reduction; using LOCF or a completer analysis; lasting four to eight weeks; and where the numbers of participants and studies were small. </p> </li> </ul> </p> </section> <section id="CD008314-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned for all analyses to be according to individual painful conditions, because placebo response rates with the same outcome can vary between conditions, as can the drug‐specific effects (<a href="./references#CD008314-bbs2-0046" title="MooreRA , StraubeS , WiffenPJ , DerryS , McQuayHJ . Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007076.pub2] ">Moore 2009</a>). We did not plan subgroup analyses since experience of previous reviews indicated that there would be too few data for any meaningful subgroup analysis. </p> </section> <section id="CD008314-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>We planned no sensitivity analysis because the evidence base was known to be too small to allow reliable analysis, and we decided that results from neuropathic pain of different origins would not be pooled in the primary analyses. We would have examined details of dose escalation schedules in the unlikely situation that these could have provided some basis for a sensitivity analysis. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008314-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008314-sec-0052"></div> <section id="CD008314-sec-0053"> <h3 class="title">Description of studies</h3> <section id="CD008314-sec-0054"> <h4 class="title">Results of the search</h4> <p>Searches found 679 possible titles, which we examined for possible inclusion (<a href="#CD008314-fig-0001">Figure 1</a>). We examined 10 in detail. We included four and excluded four. One further study (<a href="./references#CD008314-bbs2-0010" title="WangQP , BaiM . Topiramate versus carbamazepine for the treatment of classical trigeminal neuralgia: a meta‐analysis. CNS Drugs2011;25(10):847‐57. [DOI: 10.2165/11595590‐000000000‐00000; PUBMED: 21936587] ">Wang 2011</a>) was a meta‐analysis of six Chinese‐language studies of topiramate in trigeminal neuralgia. The methodological quality of the individual studies was described as poor, and so we placed the report into the category of awaiting classification, as none of the individual studies were obtainable. We identified another study in orofacial pain, but could find no results (<a href="./references#CD008314-bbs2-0009" title="National Institute of Dental and Craniofacial Research (NIDCR). Studies of dextromethorphan and topiramate to treat oral and facial pain. clinicaltrials.gov/show/NCT00001725 2002 (accessed 9 May 2013). ">NCT00001725</a>). </p> </section> <section id="CD008314-sec-0055"> <h4 class="title">Included studies</h4> <p>We included four studies, three in painful diabetic neuropathy (1643 participants: <a href="./references#CD008314-bbs2-0002" title="FreemanR . A double‐blind, placebo‐controlled, parallel group study to evaluate the effect of topiramate on electrophysiologic parameters in subjects with diabetic peripheral polyneuropathy. apps.who.int/trialsearch/Trial.aspx?TrialID=NCT00231673 (accessed 9 May 2013). ">NCT00231673</a>; <a href="./references#CD008314-bbs2-0003" title="RaskinP , DonofrioPD , RosenthalNR , HewittDJ , JordanDM , XiangJ , et al (CAPSS‐141 Study Group). Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology2004;63(5):865‐73. [DOI: 10.1212/01.WNL.0000137341.89781.14; PUBMED: 15365138] ">Raskin 2004</a>; <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a>) and one in lumbar radiculopathy (41 participants: <a href="./references#CD008314-bbs2-0001" title="KhoromiS , PatsalidesA , ParadaS , SalehiV , MeeganJM , MaxMB . Topiramate in chronic lumbar radicular pain. Journal of Pain2005;6(12):829‐36. [DOI: 10.1016/j.jpain.2005.08.002; PUBMED: 16326371] ">Khoromi 2005</a>). <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a> reported on 1259 participants from three separate randomised trials, mainly as pooled data. </p> <p>The mean age of participants in the studies was 58 to 59 years, and the proportion of men was 50% to 58%. </p> <p>Participants with painful diabetic neuropathy had bilateral symptoms (<a href="./references#CD008314-bbs2-0003" title="RaskinP , DonofrioPD , RosenthalNR , HewittDJ , JordanDM , XiangJ , et al (CAPSS‐141 Study Group). Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology2004;63(5):865‐73. [DOI: 10.1212/01.WNL.0000137341.89781.14; PUBMED: 15365138] ">Raskin 2004</a>; <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a>), had been on stable anti‐diabetic treatment regimens for at least three months with HbA1c ≤ 11% (≤ 97 mmol/mol), and had pain of at least 4/10 (numerical rating scale) at baseline, following analgesic washout. <a href="./references#CD008314-bbs2-0002" title="FreemanR . A double‐blind, placebo‐controlled, parallel group study to evaluate the effect of topiramate on electrophysiologic parameters in subjects with diabetic peripheral polyneuropathy. apps.who.int/trialsearch/Trial.aspx?TrialID=NCT00231673 (accessed 9 May 2013). ">NCT00231673</a> recruited participants with at least mild pain, but did not report the actual pain scores at the start of treatment. Participants with lumbar radiculopathy had pain in one or both buttocks or legs associated with one or more features of radiculopathy (for example, sharp shooting pain below the knee, imaging evidence of nerve compression in the lumbar region), and had average leg pain of at least 4/10 for the past month. In all cases, pain had been present for at least three months. </p> <p>The dose of topiramate was titrated in all studies. <a href="./references#CD008314-bbs2-0002" title="FreemanR . A double‐blind, placebo‐controlled, parallel group study to evaluate the effect of topiramate on electrophysiologic parameters in subjects with diabetic peripheral polyneuropathy. apps.who.int/trialsearch/Trial.aspx?TrialID=NCT00231673 (accessed 9 May 2013). ">NCT00231673</a> titrated to 200 mg/day over six weeks. <a href="./references#CD008314-bbs2-0001" title="KhoromiS , PatsalidesA , ParadaS , SalehiV , MeeganJM , MaxMB . Topiramate in chronic lumbar radicular pain. Journal of Pain2005;6(12):829‐36. [DOI: 10.1016/j.jpain.2005.08.002; PUBMED: 16326371] ">Khoromi 2005</a> used a 50 mg starting dose and titrated to a maximum of 400 mg/day over four weeks, followed by a two‐week maintenance period at the maximum tolerated, or target, dose. <a href="./references#CD008314-bbs2-0003" title="RaskinP , DonofrioPD , RosenthalNR , HewittDJ , JordanDM , XiangJ , et al (CAPSS‐141 Study Group). Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology2004;63(5):865‐73. [DOI: 10.1212/01.WNL.0000137341.89781.14; PUBMED: 15365138] ">Raskin 2004</a> started at 25 mg/day, titrating to a maximum of 400 mg/day over eight weeks, followed by a four‐week maintenance period. <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a> also started at 25 mg/day, titrating to a maximum of 100 mg/day, 200 mg/day, or 400 mg/day over six to 10 weeks, depending on the target dose, followed by a 12‐week maintenance period. </p> <p><a href="./references#CD008314-bbs2-0002" title="FreemanR . A double‐blind, placebo‐controlled, parallel group study to evaluate the effect of topiramate on electrophysiologic parameters in subjects with diabetic peripheral polyneuropathy. apps.who.int/trialsearch/Trial.aspx?TrialID=NCT00231673 (accessed 9 May 2013). ">NCT00231673</a>, <a href="./references#CD008314-bbs2-0003" title="RaskinP , DonofrioPD , RosenthalNR , HewittDJ , JordanDM , XiangJ , et al (CAPSS‐141 Study Group). Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology2004;63(5):865‐73. [DOI: 10.1212/01.WNL.0000137341.89781.14; PUBMED: 15365138] ">Raskin 2004</a>, and <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a> were parallel studies and used an inert placebo, while <a href="./references#CD008314-bbs2-0001" title="KhoromiS , PatsalidesA , ParadaS , SalehiV , MeeganJM , MaxMB . Topiramate in chronic lumbar radicular pain. Journal of Pain2005;6(12):829‐36. [DOI: 10.1016/j.jpain.2005.08.002; PUBMED: 16326371] ">Khoromi 2005</a> was a two‐period cross‐over study with a two‐week dose‐tapering washout between periods, and used an active placebo (diphenhydramine) to mimic possible adverse events of topiramate. </p> </section> <section id="CD008314-sec-0056"> <h4 class="title">Excluded studies</h4> <p>We excluded one study after reading the full text (<a href="./references#CD008314-bbs2-0007" title="MuehlbacherM , NickelMK , KettlerC , TrittK , LahmannC , LeiberichPK , et al. Topiramate in treatment of patients with chronic low back pain: a randomized, double‐blind, placebo‐controlled study. Clinical Journal of Pain2006;22(6):526‐31. [DOI: 10.1097/.ajp.0000192516.58578.a4] ">Muehlbacher 2006</a>) as participants had back pain that was not specifically of neuropathic origin. Three other excluded studies appeared as short conference abstracts (<a href="./references#CD008314-bbs2-0005" title="EdwardsKR , GlantzMJ , LevinP . An evaluation of topiramate in the management of painful diabetic neuropathy. American Pain Society 17th Annual Scientific Meeting, San Diego November 5‐8. 1998. ">Edwards 1998</a>; <a href="./references#CD008314-bbs2-0006" title="EdwardsKR , GlantzMJ , ButtonJ , NortonJA , WhittakerT , CrossN . Efficacy and safety of topiramate in the treatment of painful diabetic neuropathy: a double‐blind, placebo‐controlled study. Neurology. 2000; Vol. 54 (Suppl 3):A81. ">Edwards 2000</a>; <a href="./references#CD008314-bbs2-0008" title="VinikA , HewittD , XiangJ , JordanD , RosenthalN . Topiramate in the treatment of painful diabetic neuropathy: results from a multicenter, randomized, double‐blind, placebo‐controlled trial. Neurology. 2003; Vol. 60 (Suppl 1):A154‐5. ">Vinik 2003</a>) and may have formed part of <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a>. </p> </section> </section> <section id="CD008314-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>Each study had at least one source of high risk of bias. <a href="#CD008314-fig-0002">Figure 2</a> illustrates the 'Risk of bias' assessments for each included study by category. </p> <div class="figure" id="CD008314-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. Red = high risk of bias, yellow = unclear risk of bias, green = low risk of bias." data-id="CD008314-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. Red = high risk of bias, yellow = unclear risk of bias, green = low risk of bias. </p> </div> </div> </div> <section id="CD008314-sec-0058"> <h4 class="title">Allocation</h4> <p>All studies were randomised. <a href="./references#CD008314-bbs2-0003" title="RaskinP , DonofrioPD , RosenthalNR , HewittDJ , JordanDM , XiangJ , et al (CAPSS‐141 Study Group). Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology2004;63(5):865‐73. [DOI: 10.1212/01.WNL.0000137341.89781.14; PUBMED: 15365138] ">Raskin 2004</a> and <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a> described the method used to produce the random sequence, but only <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a> described the method used to conceal the allocation. <a href="./references#CD008314-bbs2-0001" title="KhoromiS , PatsalidesA , ParadaS , SalehiV , MeeganJM , MaxMB . Topiramate in chronic lumbar radicular pain. Journal of Pain2005;6(12):829‐36. [DOI: 10.1016/j.jpain.2005.08.002; PUBMED: 16326371] ">Khoromi 2005</a> did not describe the method used to generate the sequence, but appeared to have used a remote method to conceal allocation. <a href="./references#CD008314-bbs2-0002" title="FreemanR . A double‐blind, placebo‐controlled, parallel group study to evaluate the effect of topiramate on electrophysiologic parameters in subjects with diabetic peripheral polyneuropathy. apps.who.int/trialsearch/Trial.aspx?TrialID=NCT00231673 (accessed 9 May 2013). ">NCT00231673</a> provided very little description of methods in a short trial report. </p> </section> <section id="CD008314-sec-0059"> <h4 class="title">Blinding</h4> <p>All studies were double‐blind. <a href="./references#CD008314-bbs2-0003" title="RaskinP , DonofrioPD , RosenthalNR , HewittDJ , JordanDM , XiangJ , et al (CAPSS‐141 Study Group). Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology2004;63(5):865‐73. [DOI: 10.1212/01.WNL.0000137341.89781.14; PUBMED: 15365138] ">Raskin 2004</a> and <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a> described the method used to maintain blinding. </p> </section> <section id="CD008314-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p>Withdrawal rates in all studies were more than 10%. <a href="./references#CD008314-bbs2-0003" title="RaskinP , DonofrioPD , RosenthalNR , HewittDJ , JordanDM , XiangJ , et al (CAPSS‐141 Study Group). Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology2004;63(5):865‐73. [DOI: 10.1212/01.WNL.0000137341.89781.14; PUBMED: 15365138] ">Raskin 2004</a> and <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a> reported that they used LOCF in evaluations of pain outcomes for participants who withdrew early, while <a href="./references#CD008314-bbs2-0001" title="KhoromiS , PatsalidesA , ParadaS , SalehiV , MeeganJM , MaxMB . Topiramate in chronic lumbar radicular pain. Journal of Pain2005;6(12):829‐36. [DOI: 10.1016/j.jpain.2005.08.002; PUBMED: 16326371] ">Khoromi 2005</a> did not report on treatment of withdrawals in analyses. We judged all studies to be at high risk of bias for this criterion, with the exception of <a href="./references#CD008314-bbs2-0002" title="FreemanR . A double‐blind, placebo‐controlled, parallel group study to evaluate the effect of topiramate on electrophysiologic parameters in subjects with diabetic peripheral polyneuropathy. apps.who.int/trialsearch/Trial.aspx?TrialID=NCT00231673 (accessed 9 May 2013). ">NCT00231673</a>, where there was an unknown risk. </p> </section> <section id="CD008314-sec-0061"> <h4 class="title">Other potential sources of bias</h4> <p>We considered two studies (<a href="./references#CD008314-bbs2-0001" title="KhoromiS , PatsalidesA , ParadaS , SalehiV , MeeganJM , MaxMB . Topiramate in chronic lumbar radicular pain. Journal of Pain2005;6(12):829‐36. [DOI: 10.1016/j.jpain.2005.08.002; PUBMED: 16326371] ">Khoromi 2005</a>; <a href="./references#CD008314-bbs2-0002" title="FreemanR . A double‐blind, placebo‐controlled, parallel group study to evaluate the effect of topiramate on electrophysiologic parameters in subjects with diabetic peripheral polyneuropathy. apps.who.int/trialsearch/Trial.aspx?TrialID=NCT00231673 (accessed 9 May 2013). ">NCT00231673</a>) to be at high risk of bias due to the small number of participants in each treatment arm. </p> </section> </section> <section id="CD008314-sec-0062"> <h3 class="title" id="CD008314-sec-0062">Effects of interventions</h3> <p>See: <a href="./full#CD008314-tbl-0001"><b>Summary of findings for the main comparison</b> Topiramate 200 to 400 mg versus placebo for neuropathic pain</a> </p> <section id="CD008314-sec-0063"> <h4 class="title">Efficacy</h4> <p>No study provided first tier evidence for an efficacy outcome.</p> <p>We judged the following results as second tier because of high withdrawal rates in all studies and use of LOCF imputation (<a href="./references#CD008314-bbs2-0003" title="RaskinP , DonofrioPD , RosenthalNR , HewittDJ , JordanDM , XiangJ , et al (CAPSS‐141 Study Group). Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology2004;63(5):865‐73. [DOI: 10.1212/01.WNL.0000137341.89781.14; PUBMED: 15365138] ">Raskin 2004</a>; <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a>) or less rigorous outcomes and unspecified imputation (<a href="./references#CD008314-bbs2-0001" title="KhoromiS , PatsalidesA , ParadaS , SalehiV , MeeganJM , MaxMB . Topiramate in chronic lumbar radicular pain. Journal of Pain2005;6(12):829‐36. [DOI: 10.1016/j.jpain.2005.08.002; PUBMED: 16326371] ">Khoromi 2005</a>; <a href="./references#CD008314-bbs2-0002" title="FreemanR . A double‐blind, placebo‐controlled, parallel group study to evaluate the effect of topiramate on electrophysiologic parameters in subjects with diabetic peripheral polyneuropathy. apps.who.int/trialsearch/Trial.aspx?TrialID=NCT00231673 (accessed 9 May 2013). ">NCT00231673</a>). </p> <p>Details of efficacy outcomes in individual studies are in <a href="./appendices#CD008314-sec-0090">Appendix 5</a>. </p> <section id="CD008314-sec-0064"> <h5 class="title">Painful diabetic neuropathy</h5> <p><a href="./references#CD008314-bbs2-0002" title="FreemanR . A double‐blind, placebo‐controlled, parallel group study to evaluate the effect of topiramate on electrophysiologic parameters in subjects with diabetic peripheral polyneuropathy. apps.who.int/trialsearch/Trial.aspx?TrialID=NCT00231673 (accessed 9 May 2013). ">NCT00231673</a> measured pain using VAS scores, but contained almost no information about pain outcomes. The report states that pain scores were not statistically different between topiramate and placebo. </p> <p>Another study (<a href="./references#CD008314-bbs2-0003" title="RaskinP , DonofrioPD , RosenthalNR , HewittDJ , JordanDM , XiangJ , et al (CAPSS‐141 Study Group). Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology2004;63(5):865‐73. [DOI: 10.1212/01.WNL.0000137341.89781.14; PUBMED: 15365138] ">Raskin 2004</a>) reported dichotomous data for pain relief; 74/208 (36%) participants experienced more than a 50% reduction in pain score from baseline to end of study with topiramate compared to 23/109 (21%) with placebo. For the less rigorous outcome of more than a 30% reduction, there were 103/208 (50%) responders with topiramate and 37/109 (34%) responders with placebo. </p> <p>The largest study (<a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a>) reported only group mean data for pain relief. In the individual studies, the mean and median VAS scores were lower at endpoint than baseline for all treatment groups, by approximately 10/100 to 20/100 points from a baseline of 55/100 to 60/100. The difference between topiramate and placebo was not significant for two of the three studies individually, irrespective of target dose. </p> </section> <section id="CD008314-sec-0065"> <h5 class="title">Lumbar radiculopathy</h5> <p><a href="./references#CD008314-bbs2-0001" title="KhoromiS , PatsalidesA , ParadaS , SalehiV , MeeganJM , MaxMB . Topiramate in chronic lumbar radicular pain. Journal of Pain2005;6(12):829‐36. [DOI: 10.1016/j.jpain.2005.08.002; PUBMED: 16326371] ">Khoromi 2005</a> reported the number of participants experiencing at least moderate pain relief, using a six‐point PGIC evaluation scale; 15/41 participants had this outcome with topiramate and 7/41 with placebo. We considered this outcome equivalent to ≥ 30% pain reduction. </p> </section> </section> <section id="CD008314-sec-0066"> <h4 class="title">Adverse events</h4> <p>For analysis of adverse event outcomes we combined data from participants with different conditions since there is no a priori reason to expect different adverse responses in these different conditions. Details of adverse event outcomes in individual studies are in <a href="./appendices#CD008314-sec-0091">Appendix 6</a>. </p> <p><a href="./references#CD008314-bbs2-0002" title="FreemanR . A double‐blind, placebo‐controlled, parallel group study to evaluate the effect of topiramate on electrophysiologic parameters in subjects with diabetic peripheral polyneuropathy. apps.who.int/trialsearch/Trial.aspx?TrialID=NCT00231673 (accessed 9 May 2013). ">NCT00231673</a> provided no information about adverse events, but reported, without any analysis presented, that adverse events generally and specific adverse events were more frequent with topiramate than placebo. Two participants (one each in the topiramate and placebo groups) had a serious adverse event. </p> <p>Two studies (<a href="./references#CD008314-bbs2-0001" title="KhoromiS , PatsalidesA , ParadaS , SalehiV , MeeganJM , MaxMB . Topiramate in chronic lumbar radicular pain. Journal of Pain2005;6(12):829‐36. [DOI: 10.1016/j.jpain.2005.08.002; PUBMED: 16326371] ">Khoromi 2005</a>; <a href="./references#CD008314-bbs2-0003" title="RaskinP , DonofrioPD , RosenthalNR , HewittDJ , JordanDM , XiangJ , et al (CAPSS‐141 Study Group). Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology2004;63(5):865‐73. [DOI: 10.1212/01.WNL.0000137341.89781.14; PUBMED: 15365138] ">Raskin 2004</a>) contributed data for participants experiencing at least one adverse event (398 participants). </p> <p> <ul id="CD008314-list-0009"> <li> <p>The proportion of participants with at least one adverse event with topiramate was 82% (204/248, range 82% to 85%). </p> </li> <li> <p>The proportion of participants with at least one adverse event with placebo was 71% (106/150). </p> </li> <li> <p>The risk ratio for topiramate compared with placebo was 1.2 (95% CI 1.04 to 1.3); the NNTH was 8.6 (95% CI 4.9 to 35) (<a href="./references#CD008314-fig-0004" title="">Analysis 1.1</a>). </p> </li> </ul> </p> <p>Two studies (<a href="./references#CD008314-bbs2-0003" title="RaskinP , DonofrioPD , RosenthalNR , HewittDJ , JordanDM , XiangJ , et al (CAPSS‐141 Study Group). Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology2004;63(5):865‐73. [DOI: 10.1212/01.WNL.0000137341.89781.14; PUBMED: 15365138] ">Raskin 2004</a>; <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a>) contributed data for participants experiencing a serious adverse event (1586 participants). We combined data from the various target doses of topiramate in <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a>. </p> <p> <ul id="CD008314-list-0010"> <li> <p>The proportion of participants experiencing a serious adverse event with topiramate was 6.6% (72/1093, range 4.8% to 7.0%). </p> </li> <li> <p>The proportion of participants experiencing a serious adverse event with placebo was 7.5% (37/493). </p> </li> <li> <p>The risk ratio for topiramate compared with placebo was 0.87 (95% CI 0.59 to 1.3); the NNTH was not calculated (<a href="./references#CD008314-fig-0005" title="">Analysis 1.2</a>). </p> </li> </ul> </p> <section id="CD008314-sec-0067"> <h5 class="title">Particular adverse events</h5> <section id="CD008314-sec-0068"> <h6 class="title">Weight loss</h6> <p><a href="./references#CD008314-bbs2-0002" title="FreemanR . A double‐blind, placebo‐controlled, parallel group study to evaluate the effect of topiramate on electrophysiologic parameters in subjects with diabetic peripheral polyneuropathy. apps.who.int/trialsearch/Trial.aspx?TrialID=NCT00231673 (accessed 9 May 2013). ">NCT00231673</a> reported average weight loss of 4.1 kg and 0.3 kg with topiramate and placebo, respectively. </p> <p><a href="./references#CD008314-bbs2-0001" title="KhoromiS , PatsalidesA , ParadaS , SalehiV , MeeganJM , MaxMB . Topiramate in chronic lumbar radicular pain. Journal of Pain2005;6(12):829‐36. [DOI: 10.1016/j.jpain.2005.08.002; PUBMED: 16326371] ">Khoromi 2005</a> did not report on weight loss; three participants in the placebo group and none in the topiramate group reported anorexia as an adverse event. </p> <p><a href="./references#CD008314-bbs2-0003" title="RaskinP , DonofrioPD , RosenthalNR , HewittDJ , JordanDM , XiangJ , et al (CAPSS‐141 Study Group). Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology2004;63(5):865‐73. [DOI: 10.1212/01.WNL.0000137341.89781.14; PUBMED: 15365138] ">Raskin 2004</a> reported a mean weight loss by the final visit in the topiramate group of 2.6 kg, compared to a mean gain of 0.2 kg in the placebo group. With topiramate, 76% experienced weight loss and 17% experienced weight gain, while with placebo, 43% experienced loss and 55% experienced gain. </p> <p><a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a> reported that most participants treated with topiramate lost weight. In the groups taking topiramate, 19% to 38% of participants experienced a weight loss by the final visit of ≥ 5% from baseline, compared with 7% of those taking placebo. </p> </section> <section id="CD008314-sec-0069"> <h6 class="title">Other particular adverse events</h6> <p>Other adverse events affecting ≥ 3% of participants included nausea and diarrhoea, fatigue, weakness, sedation and somnolence, dizziness, poor concentration, and paraesthesia. </p> <p>In participants with diabetic neuropathy, treatment with topiramate did not affect HbA1c levels in <a href="./references#CD008314-bbs2-0003" title="RaskinP , DonofrioPD , RosenthalNR , HewittDJ , JordanDM , XiangJ , et al (CAPSS‐141 Study Group). Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology2004;63(5):865‐73. [DOI: 10.1212/01.WNL.0000137341.89781.14; PUBMED: 15365138] ">Raskin 2004</a> (including a 26‐week open‐label follow‐up study), but reduced levels (≥ 0.5%) in about 60% of participants in <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a>, compared with 29% of those treated with placebo. </p> </section> <section id="CD008314-sec-0070"> <h6 class="title">Deaths</h6> <p>No deaths linked to treatment were reported. In <a href="./references#CD008314-bbs2-0002" title="FreemanR . A double‐blind, placebo‐controlled, parallel group study to evaluate the effect of topiramate on electrophysiologic parameters in subjects with diabetic peripheral polyneuropathy. apps.who.int/trialsearch/Trial.aspx?TrialID=NCT00231673 (accessed 9 May 2013). ">NCT00231673</a>, one participant died of myocardial infarction three months after stopping placebo, and following spinal surgery. </p> </section> </section> </section> <section id="CD008314-sec-0071"> <h4 class="title">Withdrawals</h4> <p>We combined data for the different conditions in analyses of withdrawals. Details of withdrawals in individual studies are in <a href="./appendices#CD008314-sec-0091">Appendix 6</a>. </p> <section id="CD008314-sec-0072"> <h5 class="title">Adverse event withdrawals</h5> <p>All studies contributed data for participants withdrawing because of an adverse event. There appeared to be an increase in adverse event withdrawals with increasing target dose in <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a>, so we have combined data for only 400 mg target doses in this analysis. </p> <p> <ul id="CD008314-list-0011"> <li> <p>The proportion of participants withdrawing because of an adverse event with topiramate was 27% (135/507, range 25% to 28%). </p> </li> <li> <p>The proportion of participants withdrawing because of an adverse event with placebo was 8.1% (43/531, range 4.9% to 8.4%). </p> </li> <li> <p>The risk ratio for withdrawal with topiramate compared with placebo was 3.4 (95% CI 2.4 to 4.7); the NNTH was 5.4 (95% CI 4.3 to 7.1) (<a href="./references#CD008314-fig-0006" title="">Analysis 1.3</a>; <a href="#CD008314-fig-0003">Figure 3</a>). </p> </li> </ul> </p> <div class="figure" id="CD008314-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Topiramate versus placebo, outcome: 1.3 Adverse event withdrawals." data-id="CD008314-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Topiramate versus placebo, outcome: 1.3 Adverse event withdrawals. </p> </div> </div> </div> <p>Including data for the 200 mg target dose in <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a> did not change the result: RR 3.2 (95% CI 2.4 to 4.3), NNTH 5.6 (95% CI 4.6 to 7.0), 1407 participants. </p> </section> <section id="CD008314-sec-0073"> <h5 class="title">Lack of efficacy withdrawals</h5> <p>All studies contributed data for participants withdrawing because of lack of efficacy. There appeared to be a decrease in lack of efficacy withdrawals with increasing target dose in <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a>, so we combined data for only 400 mg target doses in this analysis. </p> <p> <ul id="CD008314-list-0012"> <li> <p>The proportion of participants withdrawing because of lack of efficacy with topiramate was 12% (63/507, range 0% to 12%). </p> </li> <li> <p>The proportion of participants withdrawing because of lack of efficacy with placebo was 18% (98/531, range 0% to 22%). </p> </li> <li> <p>The risk ratio for withdrawal with topiramate compared with placebo was 0.68 (95% CI 0.50 to 0.93); the NNTB to prevent a lack of efficacy withdrawal was 17 (95% CI 9.6 to 60) (<a href="./references#CD008314-fig-0007" title="">Analysis 1.4</a>). </p> </li> </ul> </p> <p>Inclusion of data for the 200 mg target dose in <a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a> did not change the result: RR 0.67 (95% CI 0.52 to 0.86), NNTB to prevent a lack of efficacy withdrawal 18 (95% CI 10 to 59), 1407 participants. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008314-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008314-sec-0074"></div> <section id="CD008314-sec-0075"> <h3 class="title" id="CD008314-sec-0075">Summary of main results</h3> <p>The review found four studies, with 1684 participants, testing topiramate in two different conditions. The largest study failed to find any difference between topiramate and placebo at various doses between 100 mg and 400 mg daily. The two small studies found minimal arithmetic improvement of topiramate over placebo, despite having data treatments that were the source of significant potential positive bias. Participants given topiramate experienced more adverse events, but not serious adverse events, than placebo, and adverse event withdrawal was much higher with topiramate than placebo, affecting 27% of participants. </p> <p>There was no evidence of benefit given the potentially large biases in the way results were reported (see below); many participants withdrew from the trial because of adverse events (see <a href="./full#CD008314-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD008314-sec-0076"> <h3 class="title" id="CD008314-sec-0076">Overall completeness and applicability of evidence</h3> <p>The overall completeness and applicability of the evidence was poor. Topiramate was tested only in painful diabetic neuropathy in any numbers, and the reporting of the three studies in 1643 participants could have made estimation of efficacy better, but reporting failures limited this. </p> </section> <section id="CD008314-sec-0077"> <h3 class="title" id="CD008314-sec-0077">Quality of the evidence</h3> <p>The quality of the evidence was generally good, but data handling biases, small size, or both, compromised all three studies. The major potential bias was the use of LOCF imputation in the two largest studies and an incomplete description in the third, smallest, study. Adverse event withdrawals were 27% with topiramate and 8% with placebo, a 19% absolute difference. It has been estimated that a difference of this magnitude would be associated with an overestimation of treatment effects of around 200% (<a href="./references#CD008314-bbs2-0054" title="MooreRA , StraubeS , EcclestonC , DerryS , AldingtonD , WiffenP , et al. Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses. Pain2012;153(2):265‐8. [DOI: 10.1016/j.pain.2011.10.004] ">Moore 2012a</a>). This is major potential for bias when only trivial evidence of benefit indicates strongly that topiramate is likely to be of no benefit. </p> </section> <section id="CD008314-sec-0078"> <h3 class="title" id="CD008314-sec-0078">Potential biases in the review process</h3> <p>We know of no potential biases in the review process.</p> </section> <section id="CD008314-sec-0079"> <h3 class="title" id="CD008314-sec-0079">Agreements and disagreements with other studies or reviews</h3> <p><a href="./references#CD008314-bbs2-0016" title="CarrollDG , KlineKM , MalnarKF . Role of topiramate for the treatment of painful diabetic peripheral neuropathy. Pharmacotherapy2004;24(9):1186‐93. ">Carroll 2004</a> suggested that topiramate had been used successfully to treat painful diabetic neuropathy, based mainly on case reports, retrospective case series, open‐label studies, and abstracts of two randomised trials that seem not to have been published, except probably as part of a pooled analysis (<a href="./references#CD008314-bbs2-0004" title="ThienelU , NetoW , SchwabeSK , VijapurkarU , Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials. Acta Neurologica Scandinavica2004;110(4):221‐31. [DOI: 10.1111/j.1600‐0404.2004.00338.x; PUBMED: 15355485] ">Thienel 2004</a>). The meta‐analysis of <a href="./references#CD008314-bbs2-0010" title="WangQP , BaiM . Topiramate versus carbamazepine for the treatment of classical trigeminal neuralgia: a meta‐analysis. CNS Drugs2011;25(10):847‐57. [DOI: 10.2165/11595590‐000000000‐00000; PUBMED: 21936587] ">Wang 2011</a> of topiramate in trigeminal neuralgia in 354 participants (which appears to be of poor quality, but awaits translation and analysis of the Chinese trials therein) found no benefit over placebo after one month. A systematic review of drugs for painful diabetic neuropathy indicated that topiramate was the least effective drug examined, despite failing to acknowledge bias from imputation methods (<a href="./references#CD008314-bbs2-0063" title="SnedecorSJ , SudharshanL , CappelleriJC , SadoskyA , MehtaS , BottemanM . Systematic review and meta‐analysis of pharmacological therapies for painful diabetic peripheral neuropathy. Pain Practice2014;14(2):167‐84. [DOI: 10.1111/papr.12054] ">Snedecor 2014</a>). The results are also in broad agreement with the conclusions drawn by European guidelines (<a href="./references#CD008314-bbs2-0013" title="AttalN , CruccuG , BaronR , HaanpääM , HanssonP , JensenTS , et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology2010;17(9):1113‐e88. [DOI: 10.1111/j.1468‐1331.2010.02999.x] ">Attal 2010</a>). A systematic review of antiepileptic drugs for painful diabetic neuropathy did conclude that topiramate was effective, based on a single study and inadequate methods (<a href="./references#CD008314-bbs2-0027" title="Gutierrez‐AlvarezAM , Beltrán‐RodríguezJ , MorenoCB . Antiepileptic drugs in treatment of pain caused by diabetic neuropathy. Journal of Pain and Symptom Management2007;34(2):201‐8. [DOI: 10.1016/j.jpainsymman.2006.10.023] ">Gutierrez‐Alvarez 2007</a>). </p> <p>Of interest is the observation in an open‐label extension trial that patients taking topiramate and obtaining pain relief continue to do so over up to six months, though adverse event withdrawals continue at a high rate (<a href="./references#CD008314-bbs2-0022" title="DonofrioPD , RaskinP , RosenthalNR , HewittDJ , JordanDM , XiangJ , et al (CAPSS‐141 Study Group). Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open‐label extension study. Clinical Therapeutics2005;27(9):1420‐31. [DOI: 10.1016/j.clinthera.2005.09.011] ">Donofrio 2005</a>). The weakness of this study was that it only reported average pain scores, and individual patient data analysis would be more insightful. This is fertile ground for a discussion of the relevance or otherwise of open‐label extension studies and their relationship to efficacy from the randomised, double‐blind phase of a clinical trial. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008314-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/urn:x-wiley:14651858:media:CD008314:CD008314-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_t/tCD008314-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA (Preferred Reporting Items for Systematic Reviews) flow chart." data-id="CD008314-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA (Preferred Reporting Items for Systematic Reviews) flow chart.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/full#CD008314-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008314-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/urn:x-wiley:14651858:media:CD008314:CD008314-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_t/tCD008314-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. Red = high risk of bias, yellow = unclear risk of bias, green = low risk of bias." data-id="CD008314-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. Red = high risk of bias, yellow = unclear risk of bias, green = low risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/full#CD008314-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008314-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/urn:x-wiley:14651858:media:CD008314:CD008314-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_t/tCD008314-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Topiramate versus placebo, outcome: 1.3 Adverse event withdrawals." data-id="CD008314-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Topiramate versus placebo, outcome: 1.3 Adverse event withdrawals. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/full#CD008314-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008314-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/urn:x-wiley:14651858:media:CD008314:CD008314-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_t/tCD008314-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Topiramate versus placebo, Outcome 1 Any adverse event." data-id="CD008314-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Topiramate versus placebo, Outcome 1 Any adverse event.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/references#CD008314-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008314-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/urn:x-wiley:14651858:media:CD008314:CD008314-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_t/tCD008314-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Topiramate versus placebo, Outcome 2 Serious adverse events." data-id="CD008314-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Topiramate versus placebo, Outcome 2 Serious adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/references#CD008314-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008314-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/urn:x-wiley:14651858:media:CD008314:CD008314-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_t/tCD008314-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Topiramate versus placebo, Outcome 3 Adverse event withdrawals." data-id="CD008314-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Topiramate versus placebo, Outcome 3 Adverse event withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/references#CD008314-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008314-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/urn:x-wiley:14651858:media:CD008314:CD008314-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_t/tCD008314-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Topiramate versus placebo, Outcome 4 Lack of efficacy withdrawals." data-id="CD008314-fig-0007" src="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Topiramate versus placebo, Outcome 4 Lack of efficacy withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/references#CD008314-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/media/CDSR/CD008314/image_n/nCD008314-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD008314-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Topiramate 200 to 400 mg versus placebo for neuropathic pain</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Intervention: topiramate 200 to 400 mg compared with placebo</b> </p> <p><b>Patient or population: neuropathic pain (two studies found in painful diabetic neuropathy, and one in lumbar radiculopathy)</b> </p> <p><b>Settings: community</b> </p> <p><b>Intervention: oral topiramate 200 to 400 mg daily</b> </p> <p><b>Comparison: oral placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcome</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Probable outcome with intervention</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Probable outcome with comparator</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>NNTB or NNTH and/or relative effect (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Number of participants</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At least 50% reduction in pain or equivalent</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diabetic peripheral neuropathy</p> <p>LOCF imputation makes any estimate an overestimation, and bulk of data in studies report no difference between topiramate and placebo<br/> Low numbers </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>"Moderate" benefit</p> <p>At least 30% reduction in pain</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>317 participants</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diabetic peripheral neuropathy</p> <p>LOCF imputation makes any estimate an overestimation, and bulk of data in studies report no difference between topiramate and placebo<br/> Low numbers </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion below 30/100 mm on VAS</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Patient Global Impression of Change much or very much improved</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adequate data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>399 participants</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Variously reported, and inadequate numbers for satisfactory analysis</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse event withdrawals</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>270 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>81 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNTH 5.4 (4.3 to 7.1)</p> <p>RR 3.4 (2.4 to 4.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1038 participants</p> <p>178 events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low number of events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>66 in 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>75 in 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NNTH not calculated</p> <p>RR 0.9 (0.6 to 1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1586 participants</p> <p>110 events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate quality</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low number of events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>There were no deaths related to treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>LOCF: last observation carried forward; VAS: visual analogue scale; NNTB: number needed to treat for an additional beneficial effect: NNTH: number needed to treat for an additional harmful effect; RR: risk ratio. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Topiramate 200 to 400 mg versus placebo for neuropathic pain</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/full#CD008314-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008314-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Topiramate versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [1.04, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1586</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.59, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse event withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1038</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.35 [2.41, 4.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Lack of efficacy withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1038</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.50, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Topiramate versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008314.pub3/references#CD008314-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008314.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD008314-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD008314-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD008314-note-0001">Français</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008314\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008314\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008314\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008314\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008314\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=7LavyS58&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008314.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008314.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD008314.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD008314.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008314.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719970120"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008314.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719970123"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008314.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918df5b77c7b9368',t:'MTc0MDcxOTk3MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 